Our study showed that overall BDNF, NGF, NT-3, and NT-4 levels are higher in METH users with depression compared to METH addicts without depression (d = 0.65, 0.59, 0.76, 0.78, respectively, as shown in Table 3). This evidence concerns the gene NTF3 and depressive symptom measurement.